News
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & Dickson ...
Will Robinson, program director, LogiPharma, reveals why the conference will be moved to Vienna moving forward.
In recent times, AI has become the talk of the town for its potential applications in every sector, including logistics. When ...
Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for ...
Respective industry and government agendas could significantly reshape the US prescription drug market.
When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris O’Dell, provides an update on where the healthcare industry currently stands in terms of compliance with ...
Keeping that in mind, LogiPharma Europe wanted to find ways to remedy that challenge, and welcomed a panel discussion on “Future-Proofing for Complex Novel Modalities: How Can You Deliver Personalized ...
In the second part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris O’Dell, Turquoise Health’s SVP of market solutions, discusses the biggest challenges healthcare ...
Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.
Will Robinson, program director, LogiPharma, explains how artificial intelligence and sustainability are driving a clear shift in priorities across the pharmaceutical supply chain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results